Crossmark

SAMD9 is a (epi-) genetically regulated anti-inflammatory factor activated in RA patients

Crossref DOI link: https://doi.org/10.1007/s11010-019-03499-7

Published Online: 2019-02-04

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

He, Pei

Wu, Long-Fei

Bing, Peng-Fei

Xia, Wei

Wang, Lan

Xie, Fang-Fei

Lu, Xin

Lei, Shu-Feng

Deng, Fei-Yan
Funding

Funding for this research was provided by:

Natural Science Foundation of Jilin Province (81373010)

Natural Science Foundation of Jilin Province (81473046)

Natural Science Foundation of Jilin Province (81541068)

Natural Science Foundation of Jilin Province (31271336)

Natural Science Foundation of Jilin Province (81502868)

Natural Science Foundation of Jilin Province (31401079)

Natural Science Foundation of Jilin Province (81401343)

Natural Science Foundation of Jiangsu Province (BK20150346)

Startup Fund from Soochow University (Q413900112)

Startup Fund from Soochow University (Q413900712)
License Information

Text and Data Mining valid from 2019-02-04
More Information

Article History

Received: 1 October 2018

Accepted: 19 January 2019

First Online: 4 February 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: The study was approved by the Institutional Research Ethic Board at the Soochow University (ethics approval number: 2012-146). All the participants signed informed consent form.